Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals
Objectives Clinical failures with cefazolin have been described in high-inoculum infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) producing type A β-lactamase. We investigated the prevalence of the cefazolin inoculum effect (InE) in MSSA from South American hospitals, since...
- Autores:
-
Rincón, Sandra
Reyes, Jinnethe
Carvajal Ortiz, Lina Paola
Rojas, Natalia
Cortés, Fabián
Panesso, Diana
Guzmán, Manuel
Zurita, Jeannete
Adachi, Javier A.
Murray, Barbara E.
Nannini, Esteban C.
Arias, Cesar A.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2013
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/3761
- Acceso en línea:
- http://hdl.handle.net/20.500.12495/3761
https://doi.org/10.1093/jac/dkt254
https://repositorio.unbosque.edu.co
- Palabra clave:
- Inoculum effect
Bloodstream infections
Osteomyelitis
- Rights
- openAccess
- License
- Acceso abierto
id |
UNBOSQUE2_4e3c9d495dd6d3e05a6ef3d529a044a9 |
---|---|
oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/3761 |
network_acronym_str |
UNBOSQUE2 |
network_name_str |
Repositorio U. El Bosque |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
dc.title.translated.spa.fl_str_mv |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
title |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
spellingShingle |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals Inoculum effect Bloodstream infections Osteomyelitis |
title_short |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
title_full |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
title_fullStr |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
title_full_unstemmed |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
title_sort |
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals |
dc.creator.fl_str_mv |
Rincón, Sandra Reyes, Jinnethe Carvajal Ortiz, Lina Paola Rojas, Natalia Cortés, Fabián Panesso, Diana Guzmán, Manuel Zurita, Jeannete Adachi, Javier A. Murray, Barbara E. Nannini, Esteban C. Arias, Cesar A. |
dc.contributor.author.none.fl_str_mv |
Rincón, Sandra Reyes, Jinnethe Carvajal Ortiz, Lina Paola Rojas, Natalia Cortés, Fabián Panesso, Diana Guzmán, Manuel Zurita, Jeannete Adachi, Javier A. Murray, Barbara E. Nannini, Esteban C. Arias, Cesar A. |
dc.contributor.orcid.none.fl_str_mv |
Panesso, Diana [0000-0002-4049-9702] Carvajal Ortiz, Lina Paola [0000-0001-8301-8836] |
dc.subject.keywords.spa.fl_str_mv |
Inoculum effect Bloodstream infections Osteomyelitis |
topic |
Inoculum effect Bloodstream infections Osteomyelitis |
description |
Objectives Clinical failures with cefazolin have been described in high-inoculum infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) producing type A β-lactamase. We investigated the prevalence of the cefazolin inoculum effect (InE) in MSSA from South American hospitals, since cefazolin is used routinely against MSSA due to concerns about the in vivo efficacy of isoxazolyl penicillins. Methods MSSA isolates were recovered from bloodstream (n = 296) and osteomyelitis (n = 68) infections in two different multicentre surveillance studies performed in 2001–02 and 2006–08 in South American hospitals. We determined standard-inoculum (105cfu/mL) and high-inoculum (107 cfu/mL) cefazolin MICs. PFGE was performed on all isolates that exhibited a cefazolin InE. Multilocus sequence typing (MLST) and sequencing of part of blaZ were performed on representative isolates. Results The overall prevalence of the cefazolin InE was 36% (131 isolates). A high proportion (50%) of MSSA isolates recovered from osteomyelitis infections exhibited the InE, whereas it was observed in 33% of MSSA recovered from bloodstream infections. Interestingly, Ecuador had the highest prevalence of the InE (45%). Strikingly, 63% of MSSA isolates recovered from osteomyelitis infections in Colombia exhibited the InE. MLST revealed that MSSA isolates exhibiting the InE belonged to diverse genetic backgrounds, including ST5, ST8, ST30 and ST45, which correlated with the prevalent methicillin-resistant S. aureus clones circulating in South America. Types A (66%) and C (31%) were the most prevalent β-lactamases. Conclusions Our results show a high prevalence of the cefazolin InE associated with type A β-lactamase in MSSA isolates from Colombia and Ecuador, suggesting that treatment of deep-seated infections with cefazolin in those countries may be compromised. |
publishDate |
2013 |
dc.date.issued.none.fl_str_mv |
2013 |
dc.date.accessioned.none.fl_str_mv |
2020-08-11T20:05:06Z |
dc.date.available.none.fl_str_mv |
2020-08-11T20:05:06Z |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.local.none.fl_str_mv |
Artículo de revista |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
format |
http://purl.org/coar/resource_type/c_6501 |
dc.identifier.issn.none.fl_str_mv |
1460-2091 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12495/3761 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1093/jac/dkt254 |
dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
dc.identifier.repourl.none.fl_str_mv |
https://repositorio.unbosque.edu.co |
identifier_str_mv |
1460-2091 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque |
url |
http://hdl.handle.net/20.500.12495/3761 https://doi.org/10.1093/jac/dkt254 https://repositorio.unbosque.edu.co |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofseries.spa.fl_str_mv |
Journal of Antimicrobial Chemotherapy, 1460-2091, Vol. 68, Nro. 12, 2013, p. 2773–2778 |
dc.relation.uri.none.fl_str_mv |
https://academic.oup.com/jac/article/68/12/2773/695883 |
dc.rights.local.spa.fl_str_mv |
Acceso abierto |
dc.rights.accessrights.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto |
dc.rights.creativecommons.none.fl_str_mv |
2013-06-21 |
rights_invalid_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 2013-06-21 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Oxford University Press |
dc.publisher.journal.spa.fl_str_mv |
Journal of Antimicrobial Chemotherapy |
institution |
Universidad El Bosque |
bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/78471feb-9c3b-4f4a-9813-e80ccda84c50/download https://repositorio.unbosque.edu.co/bitstreams/b90ec6e6-aa09-4880-bfdf-adf284adcb3e/download https://repositorio.unbosque.edu.co/bitstreams/0501de9e-2e68-454a-8388-df7e4cd95da2/download https://repositorio.unbosque.edu.co/bitstreams/a278ffc3-1686-4351-b9a1-866c14202cc5/download |
bitstream.checksum.fl_str_mv |
bda376b50f91b815fe41dd72c73aa3ce 8a4605be74aa9ea9d79846c1fba20a33 7210a811635d1799e7c05fee5d259be7 e3875beb259cdff50f957aa4e3af8050 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
repository.mail.fl_str_mv |
bibliotecas@biteca.com |
_version_ |
1814100725147369472 |
spelling |
Rincón, SandraReyes, JinnetheCarvajal Ortiz, Lina PaolaRojas, NataliaCortés, FabiánPanesso, DianaGuzmán, ManuelZurita, JeanneteAdachi, Javier A.Murray, Barbara E.Nannini, Esteban C.Arias, Cesar A.Panesso, Diana [0000-0002-4049-9702]Carvajal Ortiz, Lina Paola [0000-0001-8301-8836]2020-08-11T20:05:06Z2020-08-11T20:05:06Z20131460-2091http://hdl.handle.net/20.500.12495/3761https://doi.org/10.1093/jac/dkt254instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengOxford University PressJournal of Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 1460-2091, Vol. 68, Nro. 12, 2013, p. 2773–2778https://academic.oup.com/jac/article/68/12/2773/695883Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitalsCefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitalsArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Inoculum effectBloodstream infectionsOsteomyelitisObjectives Clinical failures with cefazolin have been described in high-inoculum infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) producing type A β-lactamase. We investigated the prevalence of the cefazolin inoculum effect (InE) in MSSA from South American hospitals, since cefazolin is used routinely against MSSA due to concerns about the in vivo efficacy of isoxazolyl penicillins. Methods MSSA isolates were recovered from bloodstream (n = 296) and osteomyelitis (n = 68) infections in two different multicentre surveillance studies performed in 2001–02 and 2006–08 in South American hospitals. We determined standard-inoculum (105cfu/mL) and high-inoculum (107 cfu/mL) cefazolin MICs. PFGE was performed on all isolates that exhibited a cefazolin InE. Multilocus sequence typing (MLST) and sequencing of part of blaZ were performed on representative isolates. Results The overall prevalence of the cefazolin InE was 36% (131 isolates). A high proportion (50%) of MSSA isolates recovered from osteomyelitis infections exhibited the InE, whereas it was observed in 33% of MSSA recovered from bloodstream infections. Interestingly, Ecuador had the highest prevalence of the InE (45%). Strikingly, 63% of MSSA isolates recovered from osteomyelitis infections in Colombia exhibited the InE. MLST revealed that MSSA isolates exhibiting the InE belonged to diverse genetic backgrounds, including ST5, ST8, ST30 and ST45, which correlated with the prevalent methicillin-resistant S. aureus clones circulating in South America. Types A (66%) and C (31%) were the most prevalent β-lactamases. Conclusions Our results show a high prevalence of the cefazolin InE associated with type A β-lactamase in MSSA isolates from Colombia and Ecuador, suggesting that treatment of deep-seated infections with cefazolin in those countries may be compromised.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2013-06-21ORIGINALRincón, Sandra.pdfRincón, Sandra.pdfapplication/pdf208276https://repositorio.unbosque.edu.co/bitstreams/78471feb-9c3b-4f4a-9813-e80ccda84c50/downloadbda376b50f91b815fe41dd72c73aa3ceMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/b90ec6e6-aa09-4880-bfdf-adf284adcb3e/download8a4605be74aa9ea9d79846c1fba20a33MD52THUMBNAILRincón, Sandra.pdf.jpgRincón, Sandra.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/0501de9e-2e68-454a-8388-df7e4cd95da2/download7210a811635d1799e7c05fee5d259be7MD53TEXTRincón, Sandra.pdf.txtRincón, Sandra.pdf.txtExtracted texttext/plain39363https://repositorio.unbosque.edu.co/bitstreams/a278ffc3-1686-4351-b9a1-866c14202cc5/downloade3875beb259cdff50f957aa4e3af8050MD5420.500.12495/3761oai:repositorio.unbosque.edu.co:20.500.12495/37612024-02-07 00:48:59.221restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |